Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
293 Leser
Artikel bewerten:
(1)

Medical Device Contract Manufacturing Market Worth $149.4 billion | MarketsandMarkets

CHICAGO, March 20, 2024 /PRNewswire/ -- Medical Device Contract Manufacturing Market in terms of revenue was estimated to be worth $78.9 billion in 2024 and is poised to reach $149.4 billion by 2029, growing at a CAGR of 11.4% from 2024 to 2029 according to a new report by MarketsandMarkets. The global population is growing older, leading to an increased demand for medical devices used in diagnostics, treatment, and monitoring of age-related conditions also chronic diseases like diabetes, heart disease, and cancer are becoming increasingly prevalent worldwide, necessitating a rise in the demand for medical devices used in their management. which is expected to drive the market growth. However, stringent regulatory compliance for the approval of medical devices is expected to challenge the growth of the market.

MarketsandMarkets Logo


Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170622851

Browse in-depth TOC on "Medical Device Contract Manufacturing Market"

490 - Tables
75 - Figures
500 - Pages

Medical Device Contract Manufacturing Market Scope:

Report Coverage

Details

Market Revenue in 2024

$78.9 billion

Estimated Value by 2029

$149.4 billion

Growth Rate

Poised to grow at a CAGR of 11.4%

Market Size Available for

2019-2029

Forecast Period

2024-2029

Forecast Units

Value (USD Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

Medical Device Contract Manufacturing - Class of Device, Service, Device Type, Region

Geographies Covered

Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa and GCC countries

Report Highlights

Updated financial information / product portfolio of players

Key Market Opportunities

Potential for growth in emerging countries

Key Market Drivers

Rising aging population

"Based on medical device contract manufacturing devices by IVD device type, the IVD consumables segment is expected to grow at the highest CAGR during the forecast period."

Under IVD device type, IVD consumables is forecasted to grow at the highest CAGR from 2024 to 2029. IVD consumables, the disposable components used in In Vitro Diagnostics (tests conducted outside the living body), offer several advantages that contribute to efficient and accurate medical diagnoses. IVD consumables are designed and manufactured following strict specifications, ensuring consistent performance across various tests and batches. This minimizes the risk of errors due to variations in the testing environment.

"The primary & secondary packing segment is expected to account for the largest share, by packaging & assembly services in the medical device contract manufacturing market."

By packaging & assembly services in service segment, the medical device contract manufacturing market can be segmented into primary & secondary packing, labelling and others. The advantages of primary and secondary packaging segment by protecting the device from contamination and damage during transport, storage, and handling, is expected to drive the segment growth.

"In 2023, Europe was the region with the second largest market share in the medical device contract manufacturing market."

The medical device contract manufacturing market is segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa and GCC countries

Europe accounted for the second-largest share of the medical device contract manufacturing market in 2023. The rapidly aging population, leading to a higher demand for medical devices used in diagnosing, treating, and monitoring age-related condition is driving the growth of the medical device contract manufacturing market in the European region.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170622851

Medical Device Contract Manufacturing Market Dynamics:

Drivers:

  1. Rising aging population

Restraints:

  1. Stringent regulatory guidelines for medical devices

Opportunities:

  1. Potential for growth in emerging countries

Challenge:

  1. Lack of constant innovation to balance technological capabilities against costs

Key Market Players of Medical Device Contract Manufacturing Industry:

Key players in the medical device contract manufacturing market include Flex Ltd. (Singapore), Jabil Inc. (US), TE Connectivity Ltd. (Switzerland), Sanmina Corporation (US), Nipro Corporation (Japan), Celestica Inc. (Canada), Plexus Corp. (US), Integer Holdings Corporation (US), West Pharmaceutical Services, Inc. (US), Benchmark Electronics Inc. (US), Recipharm AB (Sweden), Gerresheimer AG (Germany), Kimball Electronics Inc. (US), Nortech Systems, Inc. (US), Nemera Development S.A. (France), Viant Medical Holdings, Inc. (US), Tecomet, Inc. (US), SMC Ltd. (US), Phillips-Medisize Corporation (US), Tessy Plastics Corp. (US), Carclo Plc (UK), Nolato GW, Inc. (US), MeHow (China), Tekni-Plex (US), and Peter's Technology (China).

A breakdown of the primary participants (supply-side) for the medical device contract manufacturing market referred to for this report is provided below:

  • By Company Type: Tier 1-40%, Tier 2-35%, and Tier 3-25%
  • By Designation: C-level-30%, Director Level-55%, and Others-15%
  • By Region: North America-20%, Europe-15%, Asia Pacific-25%, Latin America- 10%, Middle East & Africa-30%

Recent Developments of Medical Device Contract Manufacturing Industry:

  • In November 2023, Jabil Inc. announced the successful acquisition of Retronix, an innovative provider in the reclamation and refurbishment of electronic components, completed earlier this year.
  • In January 2023, Integer announced the acquisition of Pulse Technologies, Inc., a privately held technology, engineering and contract manufacturing company focused on complex micro machining of medical device components for high growth structural heart, heart pump, electrophysiology, leadless pacing, and neuromodulation markets.
  • In January 2022, MixComm, the mmWave Antennas to Algorithms pioneer, announced it has selected Advanced Microsystems Technologies, a division of Sanmina as a lead partner to productize its 5G wireless infrastructure solutions
  • In November 2021, Nipro Corporation entered into a partnership with toyobo for cellulose triacetate (CTA) dialyzers (artificial kidneys).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=170622851

Medical Device Contract Manufacturing Market - Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall medical device contract manufacturing market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

  • Analysis of key drivers (growth in medical devices market in developing countries, adoption of robotics and automation in manufacturing processes, technological advancements in medical device modalities, impact of industry 4.0 on the medical device industry), restraints (consolidation in medical devices market by acquiring small and medium-sized companies), opportunities (increasing healthcare expenditure, infrastructure, and awareness in developing countries, rising geriatric population and its associated diseases) and challenges (lack of constant innovation to balance technological capabilities against costs)
  • Market Penetration: It includes extensive information on product portfolios offered by the major players in the global medical device contract manufacturing market. The report includes various segments in market device type, class of device, service and region
  • Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global medical device contract manufacturing market.
  • Market Development: Thorough knowledge and analysis of the profitable rising markets by device type, class of device, service and region
  • Market Diversification: Comprehensive information about newly launched product and services, expanding markets, current advancements, and investments in the global medical device contract manufacturing market.
  • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of product and services, and capacities of the major competitors in the global medical device contract manufacturing market.

Related Reports:

Clinical Trial Imaging Market - Global Forecasts to 2028

Revenue Cycle Management Market - Global Forecasts to 2028

Pharmaceutical Filtration Market - Global Forecasts to 2028

eClinical Solutions Market - Global Forecasts to 2027

In Vitro Diagnostics Market - Global Forecasts to 2027

About MarketsandMarkets:

MarketsandMarkets has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/medical-device-contract-manufacturing-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/medical-device-contract-manufacturing.asp

Logo: https://mma.prnewswire.com/media/2297424/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/medical-device-contract-manufacturing-market-worth-149-4-billion--marketsandmarkets-302094157.html

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2024 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.